3rd Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$440,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription Drug Costs. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. S.1128: Ensuring Access to Generic Medications Act. H.R.5461/S.2129: Ensuring Access to Lower-Cost Medicines for Seniors Act. H.R.4692/S.574: Increasing Prescription Drug Competition Act. H.R.1790: Biologics Competition Act of 2023. Labeling of Generic Drugs and Biosimilars. H.R.4134/S.2886: Updated Drug Labeling for Patient Safety Act Hickenlooper Safe Harbor for Skinny Labeling. S.775: Increasing Transparency in Generic Drug Applications Act. S.2510: RAPID Reserve Act. Drug Shortages. END Drug Shortages Act of 2023. Stop Drug Shortages Act. H.R.3008/S.2362: Drug Shortage Prevention Act of 2023. H.R. 3810: Drug Origin Transparency Act of 2023. Stockpile of Generic Drugs. Same Strength Requirement for Biosimilars. Biosimilar Red Tape Eliminations Act. Expediting Competitive Biosimilar Competition. FDA Inspections. Shaheen-Cassidy Citizen Petition Legislation. Guthrie Priority Review Voucher. Inflation Reduction Act (IRA) Implementation. H.R.3561: PATIENT Act of 2023. Trusted Partners in Medical Supply Chains. S.2364: MAPS Act. Dunn DeLauro Valisure and Department of Defense Agreement. H.R.3793: Ensuring Access to Lifesaving Drugs Act of 2023. H.R.167: Patient Access to Urgent-Use Pharmacy Compounding Act of 2023.

LobbyistCovered position, as disclosed
CRAIG BURTON —
KARIN HESSLER —
ILHAAM JAFFER New Deputy Chief of Staff / Policy Adviser, U.S. Representative Eddie Bernice Johnson (TX-30); Advance Associate, The White House Office of Scheduling and Advance
PETER KELBEL —
KATHERINE RAAB —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO)

Bills named: H.R. 167 (118th), S. 775 (118th), H.R. 3793 (118th), H.R. 3008 (118th), H.R. 5461 (118th), H.R. 3561 (118th), S. 2364 (118th), S. 2362 (118th), H.R. 1790 (118th), H.R. 4692 (118th), S. 1114 (118th), H.R. 3810 (118th), S. 574 (118th), H.R. 4134 (118th), S. 2129 (118th), S. 2886 (118th), S. 1128 (118th), S. 2510 (118th)

Medicare/Medicaid MMM

Medicare Part D Reform. Medicare Part D Program and Generic Drugs. Medicare Part D Low Income Subsidy (LIS) Program. Medicare Part D Coverage Gap Discount Program. Medicare Part D Tiering. H.R.5461/S.2129: Ensuring Access to Lower-Cost Medicines for Seniors Act. Medicare Reimbursement for Biosimilars. Medicaid Rebate Penalty. Rebates and Pharmacy Benefit Managers (PBMs). Medicare Price Negotiation. Medicare Advantage Proposed Rule. Inflation Reduction Act (IRA) Implementation.

LobbyistCovered position, as disclosed
CRAIG BURTON —
KARIN HESSLER —
ILHAAM JAFFER New —
PETER KELBEL —
KATHERINE RAAB —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5461 (118th), S. 2129 (118th)

Copyright/Patent/Trademark CPT

Skinny Labeling. Hickenlooper Safe Harbor for Skinny Labeling. REMEDY Act. IPR Amendments. H.R.4370/S.2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. Patent Listings in Orange Book. S.150: Affordable Prescriptions for Patients Act of 2023. S.2140: Patent Eligibility Restoration Act of 2023.

LobbyistCovered position, as disclosed
KARIN HESSLER —
PETER KELBEL —
KATHERINE RAAB —

Contacted: HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); SENATE

Bills named: S. 2220 (118th), S. 2140 (118th), H.R. 4370 (118th), S. 150 (118th)

Budget/Appropriations BUD

FDA Funding. Appropriations. Continuing Resolution.

LobbyistCovered position, as disclosed
KARIN HESSLER —
ILHAAM JAFFER New —
PETER KELBEL —
KATHERINE RAAB —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

General Trade Issues. Drug Supply Chain. AAM Blueprint to Enhance the Security of the U.S. Supply Chain. Trusted Partners in Medical Supply Chains.

LobbyistCovered position, as disclosed
KARIN HESSLER —
ILHAAM JAFFER New —
PETER KELBEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.